FluidAI Medical, founded in 2014 in Canada, operates at the intersection of artificial intelligence, sensor technology, and clinical care. The company's work is centered on developing data-driven tools for surgeons and healthcare systems, built upon what is described as one of the world's largest surgical datasets. Its manufacturing operations hold ISO 13485 and MDSAP certification, a standard required for medical device production in major markets.
The company's product portfolio addresses different stages of the surgical pathway. Its flagship device, Origin™, is a real-time monitoring system that attaches to surgical drains to track the biochemical composition of effluent, with the goal of enabling early prediction of anastomotic leakage. Complementing this hardware is the Stream software suite, which includes Stream Care™ for identifying patients at risk of postoperative complications, Stream CMx™ for clinical documentation automation, and Stream Inara™, a digital companion for patient engagement.
FluidAI Medical's technical work spans real-time monitoring, artificial intelligence, medical devices, sensors, surgical data analytics, and clinical documentation automation. The company is focused on the medical technology and surgical care verticals, operating from its Canadian base to develop tools intended to improve outcomes in complex surgical procedures.
